Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares
Johnson & Johnson
-(JNJ)
XNYS:JNJ
Johnson & Johnson (JNJ) Q3 earnings, sales beat Street view; stock gains
Earnings of healthcare conglomerate Johnson & Johnson (NYSE: JNJ) increased and topped the Street view in the third quarter helped by a
Johnson & Johnson (JNJ) likely to feel the pinch in Q3
Johnson & Johnson (NYSE: JNJ) is slated to release its third-quarter earnings results on Tuesday, October 15, before the market opens. The
Three companies that are haunted by multiple lawsuits
Several companies have battled lawsuits from time to time for various reasons. However, sometimes companies face thousands of lawsuits for one reason.
Johnson & Johnson tumbles on rating downgrade, after opioid ruling
Johnson & Johnson (NYSE: JNJ) continued the slide Wednesday after suffering a big loss in the previous trading session as investor mood
These deals set a new paradigm for healthcare industry
After a busy 2018, the scale of merger and acquisition activity in the healthcare industry is expected to be high this year
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note, in line
Looming opioid epidemic calls for stricter drug regulation
Though the healthcare industry is slowly waking up to the hazards of opioid-based prescription drugs, their sale continues unabated across all markets,
Johnson & Johnson set to revitalize pharma biz; eyes ‘above-market’ growth
Drug maker Johnson & Johnson (NYSE: JNJ) is all set to embark on an extensive program to strengthen the product portfolio and
Johnson & Johnson Q1 earnings slide on flat revenue growth
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the
Calendar: Earnings of Bank of America, IBM, United Airlines, PepsiCo on queue
Bank of America, IBM, United Airlines, PepsiCo and more earnings are scheduled for the week between April 15 and 19. Check out
Earnings preview: Johnson & Johnson (JNJ) to stay buoyant in Q1 despite challenges
Johnson & Johnson (NYSE: JNJ), one of the first healthcare companies to publish quarterly results this season, will be reporting March-quarter results
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
Johnson & Johnson buys Auris Health to boost medical devices business
Establishing its foray into robotic health products, pharmaceutical giant Johnson & Johnson (JNJ) on Wednesday announced it was acquiring California-based Auris Health
Abbott earnings preview: Pharma, medical devices to drive Q4 results
Healthcare giant Abbott Laboratories (ABT) is expected to post upbeat results for the fourth quarter on Wednesday before the bell, despite the
Johnson & Johnson Q4 Earnings: stellar pharma sales help deliver upbeat results
Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings for the fourth-quarter as it posts higher-than-expected quarterly results on January 22,
Companies reporting earnings this week: Jan 22 – 25
A slew of major companies are reporting earnings this week. Healthcare giant Johnson & Johnson (JNJ) will announce fourth-quarter earnings on Tuesday
Earnings Preview: Will the talc debacle devour Johnson & Johnson in Q4?
Healthcare giant Johnson & Johnson (JNJ) will kick off pharma earnings for the fourth-quarter as it posts its quarterly and full year
Johnson & Johnson dips on revenue decline in India
Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in the year
Johnson & Johnson will spend more time in court in 2019
The tainted talc has been snowballing into a gigantic threat since 2016, and things are not looking good as Johnson & Johnson
Johnson & Johnson: Key points on the asbestos report and stock slide
Johnson & Johnson’s (JNJ) stock fell over 8% in intraday trade on Friday after Reuters published a report stating that the company